Adimab Announces Launch of Four New Proprietary Technologies | |
Compass Therapeutics Announces FDA Clearance of IND Application for Phase 2 Study of CTX-009 | |
Adimab Provides 2021 Update on Clinical Pipeline | |
Antibody Legend Tillman Gerngross Introduces Latest Company | |
Amagma Therapeutics Announces Strategic Partnership with Innovent Biologics | |
How the Upper Valley Became a Biotech Hub | |
